105 related articles for article (PubMed ID: 93747)
1. Steroid levels in cancer of the prostate--markers of tumor differentiation and adequacy of anti-androgen therapy.
Geller J; Albert J; Nachtsheim D; Loza D; Lippman S
Prog Clin Biol Res; 1979; 33():103-11. PubMed ID: 93747
[No Abstract] [Full Text] [Related]
2. Dihydrotestosterone concentration in prostate cancer tissue as a predictor of tumor differentiation and hormonal dependency.
Geller J; Albert J; de la Vega D; Loza D; Stoeltzing W
Cancer Res; 1978 Nov; 38(11 Pt 2):4349-52. PubMed ID: 81107
[TBL] [Abstract][Full Text] [Related]
3. [Hormone-dependency of the human prostate].
Robel P
Bull Cancer; 1986; 73(1):19-22. PubMed ID: 2430651
[TBL] [Abstract][Full Text] [Related]
4. Methodologic basis for the radioimmunoassay of endogenous steroids in human prostatic tissue.
Belis JA
Invest Urol; 1980 Jan; 17(4):332-6. PubMed ID: 6153177
[TBL] [Abstract][Full Text] [Related]
5. Peptide hormones, serotonin, and other cell differentiation markers in benign hyperplasia and in carcinoma of the prostate.
Abrahamsson PA; Alumets J; Wadström LB; Falkmer S; Grimelius L
Prog Clin Biol Res; 1987; 243A():489-502. PubMed ID: 2443920
[No Abstract] [Full Text] [Related]
6. Selective inhibition of prostatic tumor 5 alpha-reductase by a 4-methyl-4-azasteroid.
Kadohama N; Karr JP; Murphy GP; Sandberg AA
Cancer Res; 1984 Nov; 44(11):4947-54. PubMed ID: 6488158
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptors in benign and malignant prostatic tissue.
Lakey WH; Bruchovsky N; Callaway T; Comeau T; Lieskovsky G; Rennie P; Shnitka T; Wilkin P
Trans Am Assoc Genitourin Surg; 1979; 71():19-22. PubMed ID: 94714
[TBL] [Abstract][Full Text] [Related]
8. The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer.
Nishiyama T; Hashimoto Y; Takahashi K
Clin Cancer Res; 2004 Nov; 10(21):7121-6. PubMed ID: 15534082
[TBL] [Abstract][Full Text] [Related]
9. Steroid 5-alpha reductase type 2 activity in biopsies from malignant and normal prostatic tissues.
Oliveira OL; Koff WJ; Muraro F; Santos EB; Gomes Soares DF; Trindade VM
Clin Chim Acta; 2008 May; 391(1-2):36-40. PubMed ID: 18328817
[TBL] [Abstract][Full Text] [Related]
10. [Bromocriptine and prostatic carcinoma: testosterone metabolism in relation to tumor grading (author's transl)].
Jacobi GH; Kurth KH; Altwein JE
Urologe A; 1979 Mar; 18(2):91-8. PubMed ID: 433016
[TBL] [Abstract][Full Text] [Related]
11. Steroid 5alpha-reductase isozymes I and II in recurrent prostate cancer.
Titus MA; Gregory CW; Ford OH; Schell MJ; Maygarden SJ; Mohler JL
Clin Cancer Res; 2005 Jun; 11(12):4365-71. PubMed ID: 15958619
[TBL] [Abstract][Full Text] [Related]
12. Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer.
Titus MA; Schell MJ; Lih FB; Tomer KB; Mohler JL
Clin Cancer Res; 2005 Jul; 11(13):4653-7. PubMed ID: 16000557
[TBL] [Abstract][Full Text] [Related]
13. Steroid receptor and biochemical profiles in prostatic cancer: correlation with response to hormonal treatment.
Barrack ER; Brendler CB; Walsh PC
Prog Clin Biol Res; 1987; 243A():79-97. PubMed ID: 3309976
[No Abstract] [Full Text] [Related]
14. DHT concentrations in human prostate cancer tissue.
Geller J; Albert J; Loza D; Geller S; Stoeltzing W; de la Vega D
J Clin Endocrinol Metab; 1978 Mar; 46(3):440-4. PubMed ID: 87401
[No Abstract] [Full Text] [Related]
15. Partial characterization of stromal and epithelial forms of 5 alpha-reductase in human prostate.
Bruchovsky N; McLoughlin MG; Rennie PS; To MP
Prog Clin Biol Res; 1981; 75A():161-75. PubMed ID: 6175974
[No Abstract] [Full Text] [Related]
16. [Hormonal receptors and other procedures for predicting clinical response in cancer of the prostate].
Habib FK; Chisholm GD
Arch Esp Urol; 1984 Dec; 37 Suppl 2():751-9. PubMed ID: 6085672
[No Abstract] [Full Text] [Related]
17. 5alpha-reductase type 1 immunostaining is enhanced in some prostate cancers compared with benign prostatic hyperplasia epithelium.
Thomas LN; Douglas RC; Vessey JP; Gupta R; Fontaine D; Norman RW; Thompson IM; Troyer DA; Rittmaster RS; Lazier CB
J Urol; 2003 Nov; 170(5):2019-25. PubMed ID: 14532845
[TBL] [Abstract][Full Text] [Related]
18. [Zinc in the human prostate].
Larue JP; Morfin RF; Charles JF
J Urol (Paris); 1985; 91(7):463-8. PubMed ID: 2418124
[TBL] [Abstract][Full Text] [Related]
19. A preliminary report on the measurement of cytosolic and nuclear prostatic tissue steroid receptors.
Olsson CA; deVere White R; Goldstein I; Traish AM; Müller RE; Wotiz HH
Prog Clin Biol Res; 1979; 33():209-21. PubMed ID: 93750
[No Abstract] [Full Text] [Related]
20. 5alpha-reductase isozymes and androgen actions in the prostate.
Zhu YS; Imperato-McGinley JL
Ann N Y Acad Sci; 2009 Feb; 1155():43-56. PubMed ID: 19250191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
